Articles
- Multiple sclerosis immunologyThe healthy immune system vs the MS immune systemLloyd H. Kasper, Jennifer Shoemaker
- The interplay between the immune and central nervous systems in neuronal injuryV. Wee Yong, Steven Marks
- Interferon-β mechanisms of action in multiple sclerosisSuhayl Dhib-Jalbut, Steven Marks
- The mechanism of action of glatiramer acetate treatment in multiple sclerosisMichael K. Racke, Amy E. Lovett-Racke, Nitin J. Karandikar
- Monoclonal antibodies in MSMechanisms of actionBibiana Bielekova, Brenda L. Becker
- Mitoxantrone and cytotoxic drugs' mechanisms of actionTimothy Vollmer, Thomas Stewart, Nancy Baxter
- Emerging multiple sclerosis oral therapiesKottil W. Rammohan, Jennifer Shoemaker
- Magnetic resonance imaging and treatment effects of multiple sclerosis therapeuticsThomas P. Leist, Steven Marks
- Multiple sclerosis pharmacogenomicsMaximizing efficacy of therapyDerek J. Pappas, Jorge R. Oksenberg
Introduction
- Disease-modifying drugs: Mechanisms of action and the future of multiple sclerosis therapeuticsSuhayl Dhib-Jalbut, Jonathan M. Kay
Commentary